German Cancer Research Center (DKFZ)
With more than 3,000 employees, the DKFZ is the largest biomedical research institution in Germany. Scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully.
The DKFZ's Cancer Information Service (KID) provides patients, interested parties and experts with individual answers to all questions relating to cancer. In order to transfer promising approaches from cancer research to the clinic and thus improve the chances of patients, the DKFZ operates translational centers together with excellent university hospitals and research institutions throughout Germany:
- National Center for Tumor Diseases (NCT, 6 sites)
- German Consortium for Translational Cancer Research (DKTK, 8 sites)
- Hopp Children's Tumor Center (KiTZ) Heidelberg
- Helmholtz Institute for Translational Oncology (HI-TRON) Mainz - a Helmholtz Institute of the DKFZ
- DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
- National Cancer Prevention Center (together with German Cancer Aid)
The DKFZ is funded 90 percent by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg and is a member of the Helmholtz Association of German Research Centers.
